$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$250.04M
Market Cap
-
P/E Ratio
-1.67
EPS
$4.53
52 Week High
$1.08
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
C4 Therapeutics, Inc. is an innovative biopharmaceutical company based in Watertown, Massachusetts, focused on developing advanced therapeutic candidates that selectively target and degrade disease-causing proteins. Specializing in oncology and neurodegenerative diseases, the company's proprietary dynamic protein degradation platform utilizes state-of-the-art biological mechanisms to offer groundbreaking treatment solutions for patients with significant unmet medical needs. Positioned as a leader in the biopharmaceutical industry, C4 Therapeutics is dedicated to transforming patient care by redefining treatment paradigms and improving clinical outcomes through its pioneering approaches.
LPTX
KIND
IVP
F
KVUE
KAVL
ADAP
WOK
HOOD
RR
NIO
PFE
NVDA
ASBP
PLTD
AMD
CDE
SNAP
MTSR
TSLA
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
MSTR
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
PLUG
MDLZ
NKE
JOBY
NVTS
TSM
XOM
ASTS
INTC
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP
AUR
VICI
AGNC
LPTX
KIND
IVP
F
KVUE
KAVL
ADAP
WOK
HOOD
RR
NIO
PFE
NVDA
ASBP
PLTD
AMD
CDE
SNAP
MTSR
TSLA
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
MSTR
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
PLUG
MDLZ
NKE
JOBY
NVTS
TSM
XOM
ASTS
INTC
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP
AUR
VICI
AGNC